| Fiscal Period | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Period End Date | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
| Issuance( Retirement)of Debt Net | -6.75 | -26.50 | -26.78 | -27.42 |
| Net Changein Cash | -14.24 | 11.64 | 2.83 | -4.48 |
| Cash Taxes Paid | 109.42 | 103.35 | 70.28 | 60.79 |
| Net Income/ Starting Line | 494.55 | 412.56 | 322.01 | 237.52 |
| Total Cash Dividends Paid | -91.54 | -71.45 | -53.56 | - |
| Changesin Working Capital | -280.18 | -184.53 | -124.86 | -82.84 |
| Cashfrom Operating Activities | 244.52 | 265.47 | 246.00 | 207.48 |
| Cash Interest Paid | 0.63 | 2.65 | 3.78 | 5.31 |
| Cashfrom Financing Activities | -98.77 | -99.21 | -85.22 | -100.16 |
| Depreciation/ Depletion | 54.37 | 53.59 | 54.03 | 50.05 |
| Other Investing Cash Flow Items Total | -48.81 | -68.92 | -12.87 | 43.72 |
| Capital Expenditures | -111.17 | -85.69 | -145.08 | -155.51 |
| period Type | - | - | - | - |
| Non- Cash Items | -24.23 | -16.16 | -5.19 | 2.75 |
| Financing Cash Flow Items | -0.48 | -1.26 | -4.88 | -72.75 |
| period Length | 12.00 | 12.00 | 12.00 | 12.00 |
| Cashfrom Investing Activities | -159.99 | -154.61 | -157.95 | -111.79 |
Concord Biotech Dividend Concord Biotech Bonus Concord Biotech News Concord Biotech AGM Concord Biotech Rights Concord Biotech Splits Concord Biotech Board Meetings Concord Biotech Key Metrics Concord Biotech Shareholdings Concord Biotech Profit Loss Concord Biotech Balance Sheet Concord Biotech Q1 Results Concord Biotech Q2 Results Concord Biotech Q3 Results Concord Biotech Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks